Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|November 30, 2012
[Anaphylaxis after iron dextran administration in a pregnant woman]Madeleine S Q Kortenhorst, Ankie M Harmsze, Tom H M Hasaart
The Prostate|May 5, 2007
Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivoShabana Shabbeer, Madeleine S Q Kortenhorst, Sushant Kachhap, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 9, 2014
[Shock in pregnancy: foetal distress may be the first symptom]Tineke F M Vergeldt, Madeleine S Q Kortenhorst, Tom H M Hasaart, et al.
Cancer Biology & Therapy|March 24, 2009
Hybrids of aneuploid human cancer cells permit complementation of simple and complex cancer defectsDavid A Dezentje, Dan E Arking, Madeleine S Q Kortenhorst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
A multiple-loop, double-cube microarray design applied to prostate cancer cell lines with variable sensitivity to histone deacetylase inhibitorsMadeleine S Q Kortenhorst, Marianna Zahurak, Shabana Shabbeer, et al.
Molecular Cancer Therapeutics|April 18, 2009
Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivoMadeleine S Q Kortenhorst, Sumit Isharwal, Paul J van Diest, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 26, 2013
Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitorsMichel D Wissing, Janet Mendonca, Madeleine S Q Kortenhorst, et al.
Epigenetics|July 25, 2013
Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitorsMadeleine S Q Kortenhorst, Michel D Wissing, Ronald Rodríguez, et al.
Cancer Medicine|July 4, 2014
Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancerChanning J Paller, Michel D Wissing, Janet Mendonca, et al.
Plos One|June 30, 2010
Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factorSushant K Kachhap, Nadine Rosmus, Spencer J Collis, et al.
Pageof 1